drugset / Trial / NCT07388615

The Effect of Echinacea (Immulant ®) in the Treatment of CRYPTOSPORIDIOSIS in Immunocompromised Children

NCT07388615

Phase 2 Recruiting 60 enrolled Al-Azhar University
NaSingle-groupOpen-labelTreatment

Summary

This study aims to: 1. To evaluate the effectiveness of Immulant ® addition to standard treatment in reducing clinical symptoms of Cryptosporidiosis in immunocompromised children. 2. To measure the changes in parasite count in stool samples after treatment with Immulant ®. 3. To assess the safety and tolerability of Immulant ® in children participating in the study.

Timeline

Start
2026-01-18
Primary completion
2026-06
Completion
2026-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator ECHINACEA, UNSPECIFIED Traditional medicine (herbal / TCM)

Indications